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Purpose: This study aims to assess the change in and predictive factors of the quality of life (QoL) of 
institutionalized older adults with dementia over a 20-month period. 
Methods: Information was used from a follow-up study conducted over an average period of 
19.61±1.93 months on a sample of 274 institutionalized older adults aged 60 or over, diagnosed with 
dementia. Two linear regression models were built to predict change in the EQ-5D index and the 
Quality of life in Alzheimer Disease (QOL-AD) scale, taking as independent variables: 
sociodemographic characteristics and measures of functional ability (Barthel Index), depression in 
dementia (Cornell Scale), number of chronic health problems, cognitive level (MEC, the Spanish Mini 
Mental State Examination) and severity of dementia (Clinical Dementia Rating) at baseline. 
Results: The majority of the participants were women (81.75%) with an average age of 84.70±6.51 
years, single (78.15%), with severe dementia and moderate functional dependence. There was a 
significant decrease on the EQ-5D, EQ-VAS and QOL-AD between baseline and follow-up scores. 
The main predictors of QoL of the institutionalized older adults with dementia were the number of 
chronic problems and baseline scores of the QoL measures.  
Conclusions: A significant decrease in the QoL of institutionalized older adults was observed over a 
20-month period. Results suggest that interventions aimed at reducing the number of chronic medical 
conditions may have a beneficial effect on older adults’ QoL.  
 
Keywords: Dementia, quality of life, older adults, institutionalization, follow-up study. 
 
INTRODUCTION 
Dementia is defined as an acquired chronic brain syndrome, progressive in nature, which affects 
cognitive and behavioural functions and the ability to carry out daily activities [1,2]. Although the risk 
rises exponentially with age, dementia is not considered a natural ageing process [3]. The most frequent 
cause of dementia in the elderly population is Alzheimer’s Disease [1].  
The report “Dementia: A Public Health Priority” [4] indicates the need to implement, develop and 
strengthen health and social policies to promote social well-being and an improvement in the quality 
of life (QoL) of people with dementia and their carers. The WHO defines QoL as “the individuals’ 
perception of their position in life in the context of the culture and value systems in which they live 
and in relation to their goals, expectations, standards and concerns” [5]. QoL evaluation introduces a 
humanistic element in the assessment of the disease, providing patient-centred and patient-generated 
information.  
In recent years, several dementia-specific instruments of QoL have been developed in older adults with 
dementia, such as QOL-AD [6], ADRQL [7] QUALID [8]. Generic measures such as the EQ-5D have 
also been used in samples with dementia [9,6,10]. While disease specific questionnaires provide 
particular information about the medical condition, generic measures allow for comparison with 
populations with other health conditions or the general population. Cross-sectional studies on QoL 
determinants in older adults with dementia have helped identify the most important associated aspects 
or determinants of their QoL, including mental state, health, functional abilities, level of activity and 
leisure activities, or social integration [7,11-13]. Longitudinal studies have also found similar results 
in terms of QoL predictors [14-19] and concur that baseline QoL is a significant predictor of QoL 
 
during follow-up, while functional state and cognition measures were not significant in most of the 
studies [16-19].  
The residential care environment is suitable for analyzing the QoL of people with dementia, because it 
has a very high prevalence (61.7% in Spain) [20] compared to the community (10.9%, estimated 
prevalence in Central and North-Eastern Spain using door-to-door surveys [21]). Moreover, there are 
few QoL assessment longitudinal studies in institutionalized elderly patients diagnosed with dementia. 
A previous study described a small decline in QoL ratings over two years in a cohort of 47 patients 
[18]. 
The aim of this study was to assess the change in the QoL of an institutionalized sample of older adults 
with dementia, and to assess the influence of various sociodemographic and clinical variables on QoL 
measured at follow-up.  
METHODS 
Study design and sample 
A multicenter longitudinal study was carried out by surveying people aged 60 or over diagnosed with 
dementia, according to DSM-IV-TR criteria [2], cared for in 14 residential care facilities in 10 Spanish 
provinces, including 3 facilities located in a rural environment. The residential care facilities were 
managed by two private companies who participated in the research project. Although follow-up time 
had been planned for 18 months, the time between the first and the second assessment was actually 
19.61 ± 1.93 months. The baseline study consisted of a convenience sample of 525 people. The follow-
up sample amounted to 52.19% (274 people) of the initial sample, including all the participants who 
did not leave the study. The reasons for not participating were as follows: 3 residential care facilities 
 
decided not to continue in the study (90 cases, 17.14% of the initial sample), change of residential care 
(23 individuals, 4.38%) and death (138 individuals, 26.29%). The residents (or their legal 
representatives) signed an informed consent. The study was approved by the Ethics Committee of the 
Carlos III Institute of Health. 
Measurements 
The baseline study included sociodemographic characteristics and variables describing the leisure 
activities, children alive, and frequency of contact with family members, friends or neighbors, all 
answered by proxy. The following instruments were applied to measure the QoL: the EQ-5D 
questionnaire [22], a generic health-related QoL measure previously validated in a sample with 
dementia [23]; and the Quality of Life scale in Alzheimer Disease (QOL-AD, proxy version), which 
measures QoL in Alzheimer Disease and is appropriate for dementia in general [24]. The Barthel Index 
[25] was used to assess functional ability and the Cornell Scale for Depression in Dementia [26] was 
used to evaluate the presence of depressive symptoms. The number of chronic health problems was 
recorded through a check-list based on the adapted version of the CIRS-G comorbidity scale [27]. To 
assess the cognitive level, the MEC [25], an adapted version of the Mini Mental State Examination 
(MMSE) validated in Spain, was used [28]. Information on the severity of dementia was collected 
through the Clinical Dementia Rating Scale (CDR) [29]. In the follow-up phase, the EQ-5D, QOL-AD 
and CDR questionnaires were administered.  
The EQ-5D is a generic multidimensional instrument to measure the QoL and self-perceived state of 
health, validated in Spain [30]. It has the advantage of allowing to compare different populations. To 
overcome the difficulty of measuring QoL in our study population (older adults with dementia), the 
proxy version was used [31]. The EQ-5D can be expressed as an index value resulting from the 
 
combination of responses in 5 dimensions, using the time trade-off method for the Spanish population 
[30]. The index ranges between 0 (worst state of health) and 1 (best state of health),  although there are 
negative values for those states of health considered worse than death [32]. There was 11 (2.10%) and 
1 (0.36%) missing cases, for basal line and follow-up, respectively. The second part of the EQ-5D 
measures today's state of health using a Visual Analogue Scale (EQ-VAS), and ranges between 0 (worst 
state of health imaginable) and 100 (best state of health imaginable). The QOL-AD scale measures the 
QoL in the geriatric population with dementia, bearing in mind the four most important areas of QoL: 
psychological well-being, self-perceived QoL, level of ability and environmental factors [24,33]. It 
consists of 13 items, assessed on a scale with four response options, from 1 (poor) to 4 (excellent). The 
total sumscore ranges from 13 to 52. 
The paper-and-pencil questionnaires were applied face-to-face by trained staff. The EQ-5D and QOL-
AD scales were answered by proxy by a family member or friend or, in their absence, the worker at 
the nursing home in closest contact with the resident. The proxies were identical at baseline and follow-
up in 97.70% of all cases. The Barthel Index, the Cornell Scale, the MEC and the comorbidity scale 
were completed by the medical staff at the nursing home. 
Statistical analysis  
After checking whether the continuous variables followed a normal distribution, a descriptive analysis 
of the sample baseline characteristics was performed. The Pearson's chi-squared test (χ²) was used to 
compare the proportions of the categorical variables between the groups of older adults, that remained 
in the study, were deceased or lost at follow-up. For continuous variables (age, number of chronic 
health problems, the EQ-5D index, EQ-VAS and the QOL-AD scale), the ANOVA parametric test was 
 
used, while for the Barthel Index and the Cornell Scale, the Kruskal-Wallis non-parametric test was 
applied.  
 
The Student t-test for related samples was used to analyze the changes in the QoL and health status 
(EQ-VAS) scores between the baseline and follow-up. The McNemar test was used to assess the 
changes in the CDR, categorized into two groups in order to achieve similar proportions: mild/moderate 
and severe dementia. The QoL and health status difference between the baseline and follow-up, relative 
change ([MeanT2-Mean T1]*100/MeanT1), effect size ([MeanT2-Mean T1]/SDT1, SD=Standard deviation) 
and the cumulative distribution function of responses (CDF) was also calculated [34].  
Three multiple linear regression models were built with the same independent variables to analyze the 
factors associated with the QoL and health status in the follow-up, using as dependent variables the 
EQ-5D index, EQ-VAS and QOL-AD. A three block nested design was used for each regression model. 
The first block included sex, age, marital status and the type of person who answered the questionnaire 
as independent variables. The second block included, jointly with the first block variables, the health-
related variables (Barthel Index, Cornell Scale, number of chronic problems, MEC and CDR in two 
categories), the variables on participation in passive, active, cultural and social leisure, children alive, 
and the frequency of contact with family members, friends or neighbors. The third block included, 
together with the first and second block variables, the follow-up time in months, and the dependent 
variable at baseline.  
The basic assumptions of the multiple linear regression models (independence, normality, linearity and 
homoscedasticity) were confirmed by visual inspection of the residual plots. In addition, all models 
obtained met the assumption of non-collinearity. We used a Bonferroni adjustment, with an alpha level 
 
of 0.05/18=0.003. The statistical analyses were performed with the IBM SPSS 19 program (IBM/SPSS, 
Armonk, NY, USA). 
 
RESULTS 
The baseline sample was formed by 525 residents with a mean age ± standard deviation of 85.59 ± 
6.74 years, 82.67% were women, 18.8% were married, and 71.6% had contact with families once a 
week or more often. The means of EQ-5D index, EQ-VAS and QOL-AD were 0.11 ± 0.38, 51.54 ± 
21.47 and 27.26 ± 5.14, respectively. The mean values of the other scales showed a population with 
severe dependence, depressive disorders and severe cognitive impairment (Barthel Index of 32.82 ± 
29.54, Cornell scale of 7.13 ± 6.17, and MEC of 13.24 ± 8.07). Table 1 shows the sociodemographic 
characteristics and the QoL scores of the study subjects. Compared to the groups of deceased and cases 
lost at follow-up, the study sample showed significantly better initial scores for the EQ-5D index (0.18 
± 0.38), EQ-VAS (54.67 ± 20.36) and QOL-AD scale (28.47 ± 5.12), expressing a better QoL and 
health status at the beginning. 
The follow-up revealed a significant decline in the EQ-5D, EQ-VAS and QOL-AD scores compared 
to the initial scores, with small effect sizes (Table 2). An increase in the number of people diagnosed 
with severe dementia (CDR) was also observed. The results of CDF for the three scales show that the 
QoL and health status ratings worsened for more than half of residents (58.76% for the EQ-5D index, 
50.18% for the EQ-VAS and 57.35% for the QOL-AD). The percentage of older adults with no change 
(zero value) was 12.04%, 15.15% and 12.72%, respectively; and of those who improved 29.20%, 
34.67% and 29.93%, respectively. The residents whose QoL worsened presented a significantly higher 
QoL and health status values at baseline than the residents whose QoL or health status remained stable 
 
or improved (t(269)=5.753, t(269)=8.928, t(279)=6.966 for EQ-5D, EQ-VAS and QOL-AD 
respectively; p < 0.001 for all).  
Using the EQ-5D index as a dependent variable (Table 3), the first linear regression block showed that 
the professionals valued the QoL of the resident as significantly higher than the family members 
(standardized beta, β=0.28; p=0.001). In the second block, a significant positive association was 
observed with the Barthel Index (β =0.35; p=<0.001). In the third block, there were no significant 
variables at the Bonferroni corrected alpha level. The variance explained by the final model was 
29.22%. The regression with EQ-VAS as dependent variable showed in the first block no significant 
association with any of the independent variables. In the second block a higher EQ-VAS was 
significantly associated with lower number of chronic problems (β = -0.29, p = 0.001). In the third 
block, no statistically significant variables remained and final model explained a very small proportion 
of variance, only 8.91%. 
Adopting the QOL-AD scale as a dependent variable (Table 3), there were no significant variables in 
the first block. In the second block, a higher significant QoL was observed when answered by family 
members or friends (β =-0.35; p=0.001), and for residents with fewer chronic problems (β =-0.26; 
p=0.001). With an explained variance of 26.02%, the third block showed a significant association 
between a better QoL and a lower number of chronic problems (β =-0.27; p=0.001) and a significant 
positive association with the initial QOL-AD (β = 0.47; p<0.001). 
DISCUSSION 
 
The aim of our study was to assess the change of QoL and determine predictive factors in 
institutionalized older adults diagnosed with dementia. The profile of older adults in our study was 
very similar to that found in another work with similar inclusion criteria [24,20,35]. 
When comparing the follow-up sample with the deceased and lost cases, the deceased were 
significantly older and had poorer health results in the first phase of the study (“survivorship bias”), as 
expected [36]. A significant deterioration of the QoL was also observed after an average period of 20 
months follow-up in more than half of the older adults, albeit of low magnitude. Similar results were 
found in other studies [17,18]. Less than half of the sample showed an improvement in the QoL and 
health status ratings, which is similar to another study [18]. This could reflect that the residents who 
are in a worse state also receive special attention and care, which makes them improve. Further studies 
are needed to specifically address this issue.  
The QoL determinants varied according to the QoL measurement scale analyzed, justified by the 
different items of each measurement. The professional carer valued the health-related QoL (EQ-5D) 
as higher than family members, in contrast to what happened with QoL measured by the QOL-AD. A 
possible explanation would be that family members or friends, having lived with the resident in life 
phases prior to the beginning of dementia, might compare more basic aspects of the resident’s health 
with the previous situation; however, in the QOL-AD, questions are asked about relationships with 
family and friends which could be viewed more negatively when they enter the residential care. 
Although not as relevant as other predictors, the number of chronic problems was significantly 
associated with the QoL as measured by the QoL-AD: fewer chronic problems at baseline were 
associated with better subsequent QoL. Comorbidity was another significant determinant of QoL in 
other studies of older adults with dementia [37], Parkinson's disease [38] and those without dementia 
 
who live in the community [39]. The clinical recognition of chronic problems that most affect older 
adults may offer the opportunity to take proactive clinical decisions and thereby minimize the effect of 
comorbidity on the QoL [40]. The comorbidity index for the CIRS-G would have provided more 
information, but we used a modified version that did not allow the calculation of this index. 
The initial QoL scores in QOL-AD were the most important determinants of QoL in the follow-up, as 
found in other studies [14,18,19]. This suggests that it is very important to bear in mind the assessment 
of QoL of older adults when diagnosing dementia, as it helps identify the most affected aspects and to 
act accordingly to help maintain or improve the QoL of these individuals.  
Our study has certain limitations. Since our sample was obtained by convenience, and it is not a random 
sample, we cannot generalize the results to the population of institutionalized older adults with 
dementia in Spain [20,24,35]. More than half of the older adults (55.84%) were diagnosed with severe 
dementia, which led us to analyze the questionnaires answered by proxy of all the older adults. It is 
therefore important to bear in mind this aspect when comparing results with those of other studies 
based on self-perceived QoL. However, a previous study showed a good inter-rater reliability between 
proxy and self-ratings of the EQ-5D (intraclass correlation coefficient = 0.72) [23]. Another of the 
limitations of this study is the considerable loss of cases in the follow-up, although the scope of the 
loss due to deaths (26.29%) is similar to that observed in other studies [36]. Although similar to the 
one found in other studies, the explained variance of our models was not very high [14-18], which 
suggests the presence of other possible influencing factors affecting the QoL of older adults with 
dementia, such as contextual factors [41]. 
One of the strengths of our study is that, compared to other similar studies which excluded severe 
dementia [14,17,18], our results were obtained from a sample of older adults with mostly severe 
 
dementia different levels of severity of dementia, and high proportion presented severe dementia. In 
addition, the QoL was assessed through various standardized measures, with a sufficiently long follow-
up period to observe changes, which were captured by the measures used. 
CONCLUSION 
The number of chronic medical problems and QoL at baseline were predictors for QoL at follow-up. 
Knowing the original level of QoL of a person, we can predict how it will evolve and also identify 
vulnerable groups which can be the target of interventions. The relationship observed between the 
number of chronic problems and the worst QoL in the follow-up suggests that the early promotion of 
a healthy lifestyle and the introduction of preventive methods could indirectly help maintain or even 
improve the QoL of older adults.  
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Table 1. Comparison between the baseline variables of participants in the follow-up study and 











n (%) n (%) n (%) 
p-value* 
M ± SD M ± SD M ± SD 
       
Sex (Woman) 224 (81.75) 113 (81.88) 97 (85.84) 0.602 
Age 84.70±6.51 87.49± 6.96 85.43 ± 6.60 0.001 
Marital status (single) 214 (78.10) 114 (83.82) 96 (85.71) 0.147 
Children (children alive) 187 (68.25) 98 (71.01) 75 (66.37) 0.723 
Passive leisure (practices) 105 (38.46) 37 (27.41) 43 (38.05) <0.001 
Active leisure (practices) 140 (51.28) 44 (31.88) 49 (43.36) 0.073 
Cultural leisure (practices) 56 (20.51) 23 (16.67) 16 (14.16) 0.295 
Social leisure (practices) 88 (32.23) 20 (14.60) 36 (31.86) <0.001 
Who answered the 
questionnaire? (professional) 
212 (77.37) 123 (89.78) 61 (53.98) <0.001 
CDR     
<0.001 
Mild Dementia  50 (18.25) 14 (10.14) 8 (7.08) 
 
Moderate Dementia  71 (25.91) 40 (28.99) 19 (16.81) 
Severe Dementia 153 (55.84) 84 (60.87) 86 (76.11) 
Contact with families (once a 
week or more) 
190 (70.37) 98 (72.59) 82 (73.21) 0.815 
Number of chronic problems 7.33±2.84  8.03 ± 2.91 8.49 ± 2.32 0.001 
Barthel Index 38.14±29.89  24.96 ± 28.40 29.60 ± 27.70 0.001 
Cornell Scale 5.53±5.25 6.28 ± 5.87 12.09 ± 6.09 0.001 
MEC 12.96±8.51 12.65 ± 7.63 14.93 ± 7.18 0.235 
EQ-5D Index 0.18±0.38 0.03 ± 0.37 0.04 ± 0.37 0.001 
EQ-VAS 54.67±20.36 48.84 ± 23.68 46.88 ± 20.26 0.003 
QOL-AD (by proxy) 28.47±5.12 26.30 ± 4.74 25.45 ± 4.90  0.001 
 
CDR: Clinical Dementia Rating; MEC: Mini Mental State Examination; EQ-VAS: Visual Analogue 
Scale of EQ-5D; QOL-AD: Quality of Life in Alzheimer Disease, proxy version.  
* To calculate the P-Value, χ² was used for sex, mental state, children, leisure and CDR; ANOVA was 
used for frequency of contact with family members, age, comorbidity, MEC, EQ-5D Index, EQ-VAS, 




Table 2. Changes in the scores of the scales between the baseline and follow-up (n=274).  









n (%) n (%) 
p-value* 
M ± SD M ± SD 
EQ-5D index 0.18±0.38 0.06±0.38 <0.001 -0.12 -66.67 -0.32 
EQ-VAS  54.67±20.36 49.48±18.29 <0.001 -5.19 -9.49 -0.25 
QOL-AD  28.47±5.12 26.98±5.15 <0.001 -1.49 -5.23 -0.29 
CDR   <0.001    
Mild/Moderate 121 (44.16) 84 (32.55)     
Severe 153 (55.84) 174 (67.44)         
 
EQ-VAS: EQ-5D Visual Analogue Scale; QOL-AD: Quality of Life in Alzheimer Disease, carer 
version; CDR: Clinical Dementia Rating. *Note: to calculate the p-value, the matched sample Student 
t-test was used in the EQ-5D, EQ-VAS, QOL-AD variables; and McNemar in the CDR. 
 
 
Table 3. Multiple linear regression analysis of the EQ-5D index and the QOL-AD in the follow-up.  




β p-value  R2 
Standardized 
β p-value 
Block 1 0.070      0.032     
Constant (unstandardized 
coefficient) 
 0.43 0.265 
 
 27.38 <0.001 
Who answered the questionnaire? 
(1=professional) 
 0.28 0.001 
 
 -0.23 0.004 
Block 2 0.272      0.131     
Constant (unstandardized 
coefficient) 
 0.77 0.058 
 
 27.59 <0.001 
Children (1 = has living children)  -0.16 0.047   - - 
Who answered the questionnaire?       -0.35 0.001 
Social Leisure (1=Yes)      -0.18 0.043 
Barthel Index  0.35 <0.001   0.20 0.048 
Number of chronic problems      -0.26 0.001 
Block 3 0.292      0.260     
Constant (unstandardized 
coefficient) 
 1.61 0.045 
 
 16.24 0.148 
 
Social Leisure  - -   -0.22 0.007 
Number of chronic problems  -0.15 0.046   -0.27 0.001 
EQ-5D index baseline / QOL-AD 
baseline  
  0.23 0.039 
 
  0.47 < 0.001 
Block 1 controlled for sex, age and marital status; Block 2 for the MEC (Mini Mental State 
Examination), the Cornell Depression Scale, number of chronic problems, CDR (Clinical Dementia 
Rating), participation in leisure activities, children and frequency of contact with family members, 
friends or neighbours; and block 3 controlled for follow-up time and the measure at baseline. 
 
 
 
